These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23085382)

  • 1. What is behind the non-antibiotic properties of minocycline?
    Garrido-Mesa N; Zarzuelo A; Gálvez J
    Pharmacol Res; 2013 Jan; 67(1):18-30. PubMed ID: 23085382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minocycline: far beyond an antibiotic.
    Garrido-Mesa N; Zarzuelo A; Gálvez J
    Br J Pharmacol; 2013 May; 169(2):337-52. PubMed ID: 23441623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intestinal anti-inflammatory effect of minocycline in experimental colitis involves both its immunomodulatory and antimicrobial properties.
    Garrido-Mesa N; Camuesco D; Arribas B; Comalada M; Bailón E; Cueto-Sola M; Utrilla P; Nieto A; Zarzuelo A; Rodríguez-Cabezas ME; Gálvez J
    Pharmacol Res; 2011 Apr; 63(4):308-19. PubMed ID: 21193045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-apoptotic and anti-oxidative mechanisms of minocycline against sphingomyelinase/ceramide neurotoxicity: implication in Alzheimer's disease and cerebral ischemia.
    Chen SD; Yin JH; Hwang CS; Tang CM; Yang DI
    Free Radic Res; 2012 Aug; 46(8):940-50. PubMed ID: 22583533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minocycline and neurodegenerative diseases.
    Kim HS; Suh YH
    Behav Brain Res; 2009 Jan; 196(2):168-79. PubMed ID: 18977395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline and Doxycycline: More Than Antibiotics.
    Singh S; Khanna D; Kalra S
    Curr Mol Pharmacol; 2021; 14(6):1046-1065. PubMed ID: 33568043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Minocycline an Antiviral Agent? A Review of Current Literature.
    Nagarakanti S; Bishburg E
    Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):4-8. PubMed ID: 26177421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minocycline and cytoprotection: shedding new light on a shadowy controversy.
    Jordan J; Fernandez-Gomez FJ; Ramos M; Ikuta I; Aguirre N; Galindo MF
    Curr Drug Deliv; 2007 Jul; 4(3):225-31. PubMed ID: 17627496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minocycline: a bacteriostatic antibiotic with pleiotropic cardioprotective effects.
    Brenes-Salazar JA
    Can J Physiol Pharmacol; 2015 Oct; 93(10):863-6. PubMed ID: 26382908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minocycline for short-term neuroprotection.
    Elewa HF; Hilali H; Hess DC; Machado LS; Fagan SC
    Pharmacotherapy; 2006 Apr; 26(4):515-21. PubMed ID: 16553511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of minocycline in ischemia-reperfusion injury: a comprehensive review of an old drug with new implications.
    Ulgen BO; Field MG; Qureshi W; Knight RA; Stephanou A; Latchman DS; Vasquez D; Barry SP; Saravolatz L; Scarabelli GM; Faggian G; Mazzucco A; Saravolatz L; Chen-Scarabelli C; Scarabelli TM
    Recent Pat Cardiovasc Drug Discov; 2011 May; 6(2):123-32. PubMed ID: 21599619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.
    Garrison MW; Neumiller JJ; Setter SM
    Clin Ther; 2005 Jan; 27(1):12-22. PubMed ID: 15763603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetracycline derivatives and ceftriaxone, a cephalosporin antibiotic, protect neurons against apoptosis induced by ionizing radiation.
    Tikka T; Usenius T; Tenhunen M; Keinänen R; Koistinaho J
    J Neurochem; 2001 Sep; 78(6):1409-14. PubMed ID: 11579149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel modified acrylic bone cement matrix. A step forward on antibiotic delivery against multiresistant bacteria responsible for prosthetic joint infections.
    Matos AC; Gonçalves LM; Rijo P; Vaz MA; Almeida AJ; Bettencourt AF
    Mater Sci Eng C Mater Biol Appl; 2014 May; 38():218-26. PubMed ID: 24656372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minocycline protects SH-SY5Y cells from 6-hydroxydopamine by inhibiting both caspase-dependent and -independent programmed cell death.
    Ossola B; Lantto TA; Puttonen KA; Tuominen RK; Raasmaja A; Männistö PT
    J Neurosci Res; 2012 Mar; 90(3):682-90. PubMed ID: 22108958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant potential of Minocycline in Japanese Encephalitis Virus infection in murine neuroblastoma cells: correlation with membrane fluidity and cell death.
    Mishra MK; Ghosh D; Duseja R; Basu A
    Neurochem Int; 2009 Jun; 54(7):464-70. PubMed ID: 19428790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms.
    Pabreja K; Dua K; Sharma S; Padi SS; Kulkarni SK
    Eur J Pharmacol; 2011 Jul; 661(1-3):15-21. PubMed ID: 21536024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tigecycline.
    Pankey GA
    J Antimicrob Chemother; 2005 Sep; 56(3):470-80. PubMed ID: 16040625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity.
    Ahuja M; Bishnoi M; Chopra K
    Toxicology; 2008 Feb; 244(2-3):111-22. PubMed ID: 18164115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline blocks bilirubin neurotoxicity and prevents hyperbilirubinemia-induced cerebellar hypoplasia in the Gunn rat.
    Lin S; Wei X; Bales KR; Paul AB; Ma Z; Yan G; Paul SM; Du Y
    Eur J Neurosci; 2005 Jul; 22(1):21-7. PubMed ID: 16029192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.